{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:25:39Z","timestamp":1747221939042,"version":"3.40.5"},"reference-count":11,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"DOI":"10.36416\/1806-3756\/e20220445","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T17:55:29Z","timestamp":1669139729000},"page":"e20220445","source":"Crossref","is-referenced-by-count":0,"title":["Is cystic fibrosis a risk factor for COVID-19 infection or related complications?"],"prefix":"10.36416","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-5275","authenticated-orcid":false,"given":"Rodrigo","family":"A Athanazio1","sequence":"first","affiliation":[{"name":"1. Divis\u00e3o de Pneumologia, Instituto do Cora\u00e7\u00e3o, Hospital das Cl\u00ednicas, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22288","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.            Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451-2460. https:\/\/doi.org\/10.1056\/NEJMcp2009575","DOI":"10.1056\/nejmcp2009575"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.            Wat D, Doull I. Respiratory virus infections in cystic fibrosis. Paediatr Respir Rev. 2003;4(3):172-177. https:\/\/doi.org\/10.1016\/S1526-0542(03)00059-9","DOI":"10.1016\/s1526-0542(03)00059-9"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.            Camargo CC, Jacobsen LB, Wilsmann J, Silveira MN, Rossi EP, Oliveira CT, et al. Clinical characteristics and outcomes of incident cases of COVID-19 in unvaccinated adult cystic fibrosis patients in southern Brazil: a prospective cohort study conducted during the first year of the COVID-19 pandemic. J Bras Pneumol. 2022;48(6):e20220265. https:\/\/doi.org\/10.36416\/1806-3756\/e20220265","DOI":"10.36416\/1806-3756\/e20220265"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.            McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, et al. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis. J Cyst Fibros. 2020;19(6):868-871. https:\/\/doi.org\/10.1016\/j.jcf.2020.10.003","DOI":"10.1016\/j.jcf.2020.10.003"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.            Carr SB, McClenaghan E, Elbert A, Faro A, Cosgriff R, Abdrakhmanov O, et al. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study. J Cyst Fibros. 2022;21(4):e221-e231. https:\/\/doi.org\/10.2139\/ssrn.3990936","DOI":"10.2139\/ssrn.3990936"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.            Myers CN, Scott JH, Criner GJ, Cordova FC, Mamary AJ, Marchetti N, et al. COVID-19 in lung transplant recipients. Transpl Infect Dis. 2020;22(6):e13364. https:\/\/doi.org\/10.1111\/tid.13364","DOI":"10.1111\/tid.13364"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.            Messika J, Eloy P, Roux A, Hirschi S, Nieves A, Le Pavec J, et al. COVID-19 in Lung Transplant Recipients. Transplantation. 2021;105(1):177-186. https:\/\/doi.org\/10.1097\/TP.0000000000003508","DOI":"10.1097\/tp.0000000000003508"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.            Athanazio RA, Costa AN, Carraro RM, Gonzalez D, Rached SZ, Samano MN, et al. Early COVID-19 infection after lung transplantation in a patient with cystic fibrosis. Clinics (Sao Paulo). 2020;75:e2274. https:\/\/doi.org\/10.6061\/clinics\/2020\/e2274","DOI":"10.6061\/clinics\/2020\/e2274"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.            Hadj Hassine I. Covid-19 vaccines and variants of concern: A review. Rev Med Virol. 2022;32(4):e2313. https:\/\/doi.org\/10.1002\/rmv.2313","DOI":"10.1002\/rmv.2313"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.          Rad EJ, Mirza AA, Chhatwani L, Purington N, Mohabir PK. Cystic fibrosis telemedicine in the era of COVID-19. JAMIA Open. 2022;5(1):ooac005. https:\/\/doi.org\/10.1093\/jamiaopen\/ooac005","DOI":"10.1093\/jamiaopen\/ooac005"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.          Patel S, Thompson MD, Slaven JE, Sanders DB, Ren CL. Patel S, Thompson MD, Slaven JE, Sanders DB, Ren CL. Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic. Pediatr Pulmonol. 2021;56(5):1271-1273. https:\/\/doi.org\/10.1002\/ppul.25250","DOI":"10.1002\/ppul.25250"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T17:55:34Z","timestamp":1669139734000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jornaldepneumologia.com.br\/details\/3778\/en-US\/is-cystic-fibrosis-a-risk-factor-for-covid-19-infection-or-related-complications-"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":11,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20220445","relation":{},"ISSN":["1806-3756"],"issn-type":[{"type":"electronic","value":"1806-3756"}],"subject":[],"published":{"date-parts":[[2022,11,22]]}}}